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Abstract--Extracts were prepared from rat peritoneal leukocytes obtained 4 h 
after glycogen injection and assayed for proteolytic enzyme activities against 
various substrates. The substrates used included acid-denatured bovine hemo- 
globin, bovine serum albumin, a partially purified preparation of rat pulmonary 
basement membrane, bovine neck ligament elastin, and an artificial substrate 
with elastase specificity. A high level of activity was observed when hemoglobin 
was used as the substrate. The serum albumin and basement membrane prepa- 
ration were also readily hydrolyzed by the leukocyte extract. In contrast, the 
native elastin and synthetic elastase substrate were much more resistant. Al- 
though the leukocyte extract demonstrated little intrinsic elastase activity, when 
it was mixed with a commercial hog pancreatic elastase preparation, it greatly 
potentiated the elastolytic activity, suggesting the activation of a latent enzyme. 
INTRODUCTION 
Human polymorphonuclear leukocytes contain at least three distinct neu- 
tral proteases: elastase, chymotrypsin, and collagenase (1-6). Analogous 
enzymes have been identified in the leukocytes of several other species, but 
it is apparent that considerable species-dependent differences exist (7-12). 
These differences may be critical to the species differences in susceptibility 
to various pathological processes. In this report we describe the neutral 
protease activity obtained from rat granulocytes. The rat granulocytes have 
a high level of neutral protease activity when measured against a variety of 
substrates. However, when native elastin or a synthetic elastase substrate 
are used as substrates, very little activity is detected. 
1This study was supported in part by NIH grants CA29550, CA29551, and HL00889. 
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M A T E R I A L S  A N D  M E T H O D S  
Preparation of  Rat Leukocyte Extracts. Extracts were prepared from the pooled, peri- 
toneal leukocytes obtained from Sprague-Dawley rats (Charles Rivers) 4-6 h after intraperi- 
toneal injection of 0.1% glycogen in phosphate-buffered saline (13). Normally five to six 600-g 
rats were used for each preparation. After combining the cells and hypotonically lysing the 
red blood cells (if necessary), the remaining cells, which consisted of 96-98% granulocytes were 
resuspended in 6-8 ml of saline containing 0.05 M phosphate buffer at pH 7.4 and subjected 
to homogenization and three cycles of freeze-thawing. Following this, the particulate frac- 
tion was removed by eentrifugation, and the supernatant fluid was divided into l-ml portions 
and frozen at -70~ until use. From 5-6 rats 2.5-5 • 108 leukocytes were obtained. The ex- 
tracts prepared from this number of cells contained approximately 50 mg of protein when as- 
sayed by the Folin method with bovine serum albumin as the standard. 
For certain experiments the lysosomal granules were prepared from the harvested cells. 
The cells were homogenized in 0.34 M sucrose and the granule fraction separated by differential 
centrifugation (14). 
Extracts prepared from human granulocytes were used for comparison. The cells were 
obtained from leukocyte phoresis donors through the courtesy of the Connecticut Red Cross. 
Whole-cell extracts were prepared from the human cells in the exact same manner as from the 
rat cells. 
Protease Assays. In these experiments we routinely measured hemoglobin-hydrolyzing 
activity (which we define as nonspecific protease activity) and elastase activity. Hemoglobin 
hydrolytic activity was quantitated using a highly-sensitive, solid-phase assay developed by 
us previously (15, 16). In this procedure acid-denatured bovine hemoglobin (Sigma Chemical 
Co., St. Louis, Missouri) is labeled with 1251. The labeled substrate is diluted with unlabeled 
hemoglobin, and 10/~g of the material is dried onto the bottom of microtiter wells (96-well tis- 
sue culture plates from Costar, Cambridge, Massachusetts). To run the test, 200 ~1 of the test 
solution is added to each well and incubated at 37~ for 1 h. Following this, 100/~1 is withdrawn 
and counted in a gamma counter for t25I. Quadruplicate wells are used per test. Trypsin (type 
IS; 2 • crystallized from bovine pancreas; Sigma Chemical Company) is routinely used as a 
standard. In our previous study describing the solid-phase protease assay, we demonstrated 
that nearly all of the released ~2sI was associated with 10% trichloracetic acid-soluble frag- 
ments. Likewise, we demonstrated that trypsin-induced solubilization was prevented by pro- 
tease inhibitors which also blocked activity in a conventional protease assay (15). 
Although hemoglobin was the protein substrate routinely used, we also tested the ability 
of the rat granulocyte protease to hydrolyze commercially prepared bovine serum albumin 
(Sigma Chemical Company) and bovine fibrinogen (Pentex Biochemical Co., Kankakee, 
Illinois) and to hydrolyze a partially purified rat pulmonary basement membrane preparation 
(17). Each protein was labeled with 125I and treated in exactly the same way as the hemoglobin. 
Two methods were used to assess elastase activity. One was a standard colorimetric assay 
using N-succinyl-alanyl-alanyt-alanine-p-nitroanilide as the substrate (18). The substrate was 
obtained from Bachem, Inc. (Torrance, California). In the second method, [14C]elastin was 
used as the substrate. The labeled elastin was kindly supplied by Dr. Robert Senior (Depart- 
ment of Pathology, Jewish Hospital, St. Louis, Missouri). The elastin hydrolytic activity was 
determined in a standard fluid phase assay as described previously (15). Elastase (type I, 2X 
crystallize d from hog pancreas; Sigma Chemical Co.) served as a standard in the elastase assays. 
A number of protease inhibitors were used in this study. These included soybean trypsin 
inhibitor (SBTI) (type IS), lima bean trypsin inhibitor (LBTI) (type ILL), N-t~-p-tosyl-l-lysine 
chloromethyl ketone (TLCK), L-l-tosylamide-2-phenylethyl chloromethyl ketone (TPCK), 
leupeptin, and pepstatin A. All were purchased from Sigma Chemical Company. 
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RESULTS 
Protease Activity in Rat Leukocyte Extracts. Peritoneal leukocytes 
were harvested from groups of 5-6 Sprague-Dawley rats 4 h after glycogen 
injection. The leukocytes were pooled, and whole-cell extracts were pre- 
pared as described in the Materials and Methods section. The extracts were 
then analyzed for protease activity using [t25I]hemoglobin as the substrate 
in a highly sensitive solid-phase assay (15). Trypsin was used as a standard 
enzyme preparation. It can be seen in panel A of Figure 1 that 60 #g of leu- 
kocyte extract had hemoglobin-hydrolyzing activity equivalent to approxi- 
mately 0.8/~g of the crystallized trypsin preparation. 
In addition to hemoglobin-hydrotyzing activity, we also examined the 
ability of the extract protease to hydrolyze bovine albumin, bovine fibrino- 
gen, and a partially purified rat pulmonary basement membrane prepara- 
tion. All three substrates were readily hydrolyzed by the extract prepara- 
tions (data not shown). 
We next examined the rat leukocyte extract preparations for elastase 
activity. Both the synthetic substrate, succinyl-alanyl-alanyl-alanine-p- 
nitroanilide and bovine neck ligament elastin were used as substrates. Com- 
mercially available hog pancreatic elastase was used as a control enzyme 
preparation for these studies. The results shown in panel B of Figure 1 and 
in Table 1 indicate that there was very little detectable elastase activity in 
the granulocyte extracts. Sixty micrograms of extract protein gave a barely 
detectable response when assayed using the artificial substrate. To obtain 
measurable activity with this substrate, we had to use 10 times that amount 
of protein. Likewise, when native elastin was used as the substrate, 60 #g 
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Fig. 1. Hemoglobin-hydrolysis activity and elastase activity in the rat leukocyte extract 
(RLE). The standard curves were generated as described in the Materials and Methods section. 
Trypsin (crystalized from bovine pancreas) was used in the hemoglobin-hydrolysis assay (panel 
A) and hog pancreatic elastase (crystalized) was used in the elastase assay (panel B). 
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Table 1. Elastase Activity in Rat Leukocyte Extracts a 
Enzyme preparation b 
Activity (cpm + SEM of 
~4C released from bovine 
neck ligament elastin) 
Saline 207 + 31 
Trypsin 219 + 14 
Hog pancreatic elastase 2110 + 180 
Rat leukocyte extract 514 + 15 
Human leukocyte extract 1814 + 101 
aSee the Materials and Methods section for details of 
the assay. 
bThe enzyme preparations consisted of the following: 
trypsin (10/~g of crystalized bovine pancreas trypsin); 
elastase (1 /~g of hog pancreatic elastase); rat leuko- 
cyte extract (60/zg of protein), and human leukocyte 
extract (amount of extract equivalent to 0.8 tzg of 
trypsin in hemoglobin-hydrolytic activity. 
of  extract protein demonstrated only slightly more activity than either 
trypsin or the control buffer alone. In contrast the commercially available 
elastase readily hydrolyzed the elastin substrate (Table 1). For  comparison 
purposes, a human peripheral blood leukocyte extract was prepared and 
normalized to the rat leukocyte extract with regard to hemoglobin-hy- 
drolyzing activity. In contrast to the rat leukocyte extract, the human leuko- 
cyte extract demonstrated high levels of elastolytic activity. This was not 
surprising since human  leukocytes are known to contain a large amount  of 
elastase (2, 3). 
In addition to measuring hemoglobin-hydrolyzing activity and elastin- 
hydrolyzing activity in whole-cell extracts, we also examined lysosomal 
granule preparations for the same activities. The results obtained with the 
lysosomal granules were very similar to the results obtained using the whole- 
cell extracts. That  is, we obtained a high level of protease (hemoglobin 
hydrolyzing) activity under conditions in which very little detectable elas- 
tase activity was found (data not shown). 
Characteristics of Protease Activity in Rat Leukocyte Extract Prepa- 
rations. Some of the characteristics of the rat granulocyte neutral protease 
are shown in Figures 2 and 3 and in Table 2. In Figure 2 (panel A), it can 
be seen that hemoglobin-hydrolyzing activity is linear over a 100-fold range. 
Detectable activity could be seen when as little as 0.6/~g of protein were 
used. In panel B of Figure 2 it can be seen that activity was measurable over 
a pH range of 4.0-8.0. Maximal  activity was observed at pH 8.0. 
Since measurable elastase activity was observed only at the highest 
concentrations of extract used, it was not possible to determine the range 
of linearity for the activity. We did, however, determine the optimal pH 
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Fig. 2. Characteristics of the hemoglobin-hydrolysis activity in the rat leukocyte extract. 
Panel A shows the dose-response curve of the extract at pH 7.4. In panel B is shown the pH 
profile of the activity. Thirty micrograms of extract were used at each pH. Assays at pH 4 and 5 
were run in 0.05 M acetate buffer; assays at pH 6, 7, and 8 were run with 0.05 M Tris HC1 buffer 
(O--O, saline; x - x ,  rat leukocyte extract). 
for elastase activity using the synthetic ester substrate. As with the hemo- 
globin-hydrolyzing activity, the maximum response was observed at pH 8.0 
(Figure 3). Unlike the hemoglobin-hydrolyzing activity, very little elastase 
activity was detected below pH 7. 
Table 2 shows the sensitivity of both the hemoglobin-hydrolyzing ac- 
tivity and the elastase activity (measured with the synthetic substrate) to 
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Fig. 3. The pH profile of rat leukocyte extract elastase activity. The assay was carried out using 
the [14C]bovine neck ligament elastin as the substrate. Assays at pH 4 and 5 were run in 0.05 M 
acetate buffer; assays at pH 6, 7, and 8 were run with 0.05 M Tris HCI buffer ( I - ! ,  hog pancreatic 
elastase;O--O, saline; x - - •  rat leukocyte extract). 
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Table 2. Inhibition of Rat Leukocyte Extract Hemoglobin- 
Hydrolyzing Activity and Elastase Activity 
Percent inhibition of 
activity (+ SEM) 
Hemoglobin 
Inhibitor hydrolysis ~ Elastase b 
SBTI (100#g) 84 + 5 78 + 4 
LBTI (100 #g) 33 + 3 67 + 4 
TLCK (5 • 10 -3 M) 25 + 2 -15 + 3 
TPCK (5 • 10 -3 M) 47 + 3 45 + 4 
Leupeptin (25 #g) 14 + 3 - 4 + 1 
Pepstatin (25 #g) 22 + 2 - 1 + 1 
~For the hemoglobin-hydrolysis assay 250 #1 of the rat leuko- 
cyte extract (1.5 mg of protein) was mixed with 250 #1 of the 
inhibitor solution and incubated for 30 rain at 37~ Follow- 
ing this, 200 #1 from this mixture was added to each substrate 
well. The assay was then run in the normal way. 
bFor the elastase assay 100/zl of extract (600 #g of protein) was 
mixed with 100 #1 of the inhibitor solution and incubated for 
30 min at 37~ Three hundred microliters of buffer (with 
substrate) was added to this mixture and the elastase assay 
run in the normal way. 
va r ious  p ro tease  inhibi tors .  Both  the  nonspecif ic  p ro tease  act ivi ty  and  the 
e las tase  ac t iv i ty  were suscept ib le  to  SBTI ,  LBTI ,  and  T P C K .  In cont ras t ,  
T L C K ,  leupept in ,  and  peps t a t i n  were much  less effective aga ins t  both .  
On ly  m i n i m a l  inh ib i t ion  was observed  in the  hemog lob in -hydro lys i s  assay,  
and  no inh ib i t ion  was seen in the elastase assay.  
Activation of Latent Elastase by Rat Leukocyte Extract Preparations. 
Since we ob ta ined  a large a m o u n t  o f  hemog lo b in -hyd ro lyz ing  act iv i ty  bu t  
very l i t t le  e las tase  ac t iv i ty  in the  whole-cel l  ext rac ts ,  we wan ted  to  de te rmine  
if  an  e las tase  inh ib i to r  might  be presen t  in these p repa ra t ions .  To test for  
inh ib i tors ,  we mixed  var ious  quant i t ies  of  the  leukocyte  ex t rac t  p r e pa ra t i ons  
wi th  k n o w n  a m o u n t s  of  the  s t a n d a r d  hog  pancrea t i c  e lastase and  then  tested 
for  res idua l  act ivi ty.  W e  were surpr i sed  to  f ind tha t  not  only  was there no 
de tec tab le  inh ib i to ry  ac t iv i ty  bu t  ra ther ,  there  was a t r e me ndous  po ten t i a -  
t ion  of  e las tase  activity.  This  f inding  suggested tha t  there  was ei ther  a la tent  
e las tase  presen t  in the  l eukocyte  ex t rac t  which could  be ac t iva ted  by  low 
levels o f  the  hog  pancrea t i c  e lastase or  tha t  there  was la tent  elastase in the 
c o m m e r c i a l  hog  pancrea t i c  e lastase p r e p a r a t i o n  which  could  be ac t iva ted  
by  the l eukocyte  pro tease .  
To d is t inguish  be tween these two a l te rna t ive  suggest ions,  the fo l low- 
ing expe r imen t  was done.  Severa l  vials of  the  commerc ia l  elastase were 
poo l ed  and  d i lu ted  to  con ta in  min ima l ly  de tec tab le  elastase ac t iv i ty  in a 
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100-/A sample. The diluted commercial sample was then mixed with be- 
tween 0.6 and 60/~g of the leukocyte extract and the mixture assayed for 
elastase activity. Simultaneously, various concentrations of trypsin (0.1- 
100 ~tg) were also mixed with the elastase preparation and assayed. In addi- 
tion, each of the reagents were assayed separately, and the trypsin and rat 
leukocyte extracts also mixed and assayed. The results are shown in Table 
3. It can be seen clearly that both the rat leukocyte extract as well as the 
crystalline trypsin greatly potentiated the elastase activity of the commer- 
cial hog pancreatic elastase preparation. It can also be seen that the leuko- 
cyte extract was much more effective than the trypsin. Six micrograms of 
the leukocyte extract (with hemoglobin-hydrolyzing activity equivalent to 
0.08 #g of trypsin) produced as much activation as 100 #g of the pure tryp- 
sin. It can also be seen in Table 3 that when the leukocyte extract and the 
trypsin were incubated together, there was no evidence of enhanced elastase 
activity. The results shown in Table 3 were obtained using the synthetic elas- 
tase substrate. Similar results were also obtained with the protein substrates. 
Table 3. Activation of  Latent Elastase Activity in Hog 
Pancreatic Elastase Preparation a 
Enzyme Activity 
combination (OD4~0 _+- SEM) 
Saline 0.027 + 0.008 
Saline + 0.I #g HPE b 0.046 ___ 0.010 
Saline + 100 t~g trypsin 0.030 __- 0.011 
Saline + 60/~g RLE c 0.092 +__ 0.017 
Saline + 6.0/zg RLE 0.030 _+ 0.009 
Saline + 0.6 tzg RLE 0.030 _-+ 0.008 
60/zg RLE + saline 0.035 + 0.007 
60 #g RLE +_ 100/~g trypsin 0.025 _+ 0.001 
6/~g RLE + saline 0.005 _+ 0.001 
6 #g RLE + 100 #g trypsin 0.005 _+ 0.002 
100/~g trypsin + 0.1 #g HPE 0.873 + 0.040 
10/~g trypsin + 0.1 /zg HPE 0.492 _+ 0.029 
1.0 ~zg trypsin + 0.1 #g HPE 0.220 _+ 0.017 
0.1/zg trypsin + 0.1 #g HPE 0.063 _+ 0.011 
60 ~g RLE + 0.1/~g HPE 0.993 + 0.038 
6.0 #g RLE + 0.1/~g HPE 0.859 + 0.051 
0 .6#g  RLE + 0.1/~g HPE 0.497 _+ 0.028 
aThe assay was carried out as described in the Materials 
and Methods section. The various reagents were mixed 
together and incubated at 37~ for 30 min along with 
the substrate, succinyl-alanyl-alanyl-alanine-p-nitro- 
anilide. 
bHPE = hog pancreatic elastase. 
CRLE = rat leukocyte extract (hemoglobin-hydrolyz- 
ing activity equivalent to 0.8 #g of trypsin). 
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The activation of the latent activity could be detected in both the hemo- 
globin-hydrolysis assay and the [14C]elastin-hydrolysis assay. 
DISCUSSION 
Human polymorphonuclear leukocytes contain large amounts of neu- 
tral proteases. These potent degradative enzymes have the ability to atthck 
a variety of protein substrates (3, 5, 6, 19-23) and are thought to play active 
roles in a number of pathological processes. Human leukocyte elastase, in 
particular, has been linked to both arthritis and emphysema because of its 
ability to degrade proteoglycans and elastin fibers (3, 24-27). Analogous 
enzymes to those found in human neutrophils have been identified in the 
granulocytes from various species, but it is apparent that a considerable 
amount of species-dependent differences exist (7-12). If animal models are 
to be successfully used in efforts to delineate the mechanisms of various 
pathological processes that are thought to be protease-mediated, it is im- 
perative that these species-dependent differences be taken into account. In 
this report we describe functionally the neutral protease activity obtained 
from rat leukocytes. 
High levels of protease activity were detected in whole-cell prepara- 
tions and in isolated granules. When compared to crystalline bovine pan- 
creatic trypsin with regard to hemoglobin-hydrolyzing activity, 60 gg of 
the rat leukocyte extract had activity equal to approximately 0.8 tzg of tryp- 
sin. Three other proteins (i.e., albumin, fibrinogen, and a partially purified 
basement membrane preparation) were also readily hydrolyzed by the leu- 
kocyte protease. In contrast, native elastin and the synthetic elastase sub- 
strate N-succinyl-alanyl-alanyl-alanine-p-nitroanilide proved to be very 
resistant to leukocyte extract-induced hydrolysis under the conditions 
tested. 
In many respects the rat protease is similar to the neutral proteases 
obtained from the leukocytes of other mammalian species. For example, 
optimal activity (in the hemoglobin-hydrolysis assay and in the elastase 
assays) is obtained at pH 8 (8, 12). Furthermore, both activities are sus- 
ceptible to inhibition by SBTI, LBTI, and TPCK but are resistant to inhi- 
bition by TLCK, pepstatin, and leupeptin (9, 12). Whether or not the two 
activities are the result of a single enzyme or the result o f  two separate en- 
zymes cannot be determined with the presently available data. The answer 
to that question will have to await purification studies. The object of the 
present study was not to chemically characterize the enzyme(s) responsible 
for these activities but to point out the fact that, unlike the human leuko- 
cytes, the rat ceils contain a high level of protease activity but native elastin 
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and synthetic elastase substrates are relatively resistant to it. This finding 
must be taken into account when the rat is used as a model for the study of 
disease processes that are thought to be mediated by proteolytic enzymes, 
particularly elastase. Perhaps the low level of elastase activity explains why 
rats are unusually resistant to emphysema-like conditions. 
A very interesting observation made during the course of this study 
relates to the activation of latent elastase activity in the commercial elastase 
preparation by the rat granulocyte protease. The activation phenomenon 
was initially identified during attempts to determine if the granulocytes con- 
tained factors inhibitory to elastase. Cytosolic protease inhibitors in human 
leukocytes have been previously identified (28). Not only did the rat leuko- 
cyte extract not inhibit the hog pancreatic elastase but rather, greatly po- 
tentiated it. Although the activation mechanism is unknown, it could involve 
a proteolytic modification of a "proelastase" molecule since trypsin also 
demonstrated elastase activating activity. The activation of a proelastase 
molecule could be analogous to the process by which latent collagenolytic 
enzymes are activated (30, 31). Although both the rat leukocyte protease 
and crystalline trypsin potentiated the activity in the commercial elastase 
preparation, the rat leukocyte extract appeared to be much more efficient 
than the trypsin. Six micrograms of the leukocyte extract (with hemoglobin- 
hydrolyzing activity equivalent to 0.08 /.tg of trypsin) produced the same 
amount of activation as 100 #g of trypsin. 
The ability of rat leukocyte protease to activate latent elastase may 
provide a mechanism whereby active elastase could be generated at sites 
of chronic inflammation. One could postulate, for example, that if a pro- 
elastase were being released at sites where substantial numbers of the granu- 
locytes were simultaneously present, the activity of the granulocyte pro- 
tease would quickly convert the proenzyme into the active form. The likely 
candidate cell for the source of the proelastase would be the macrophage. 
This may be a moot point, however, since very recent work seems to indi- 
cate that rat macrophages, unlike those from other species, are also spe- 
cifically devoid of elastase (32). It may be that all of the inflammatory cells 
of the rat have relatively tow levels of elastase or elastase-like enzymes. If 
this turns out to be the case, the rat may be a good model in which to exam- 
ine the role of nonelastolytic neutral proteases in various pathological 
processes. 
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